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wide approach to test whether a polygenic score of envi-
ronmental sensitivity predicted response to cognitive be-
havioural therapy (CBT) in children with anxiety disorders. 
 Methods: We identified variants associated with environ-
mental sensitivity using a novel method in which within-pair 
variability in emotional problems in 1,026 monozygotic twin 
pairs was examined as a function of the pairs’ genotype. We 
created a polygenic score of environmental sensitivity based 
on the whole-genome findings and tested the score as a 
moderator of parenting on emotional problems in 1,406 
children and response to individual, group and brief parent-
led CBT in 973 children with anxiety disorders.  Results: The 
polygenic score significantly moderated the effects of par-
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 Abstract 
 Background: The differential susceptibly hypothesis sug-
gests that certain genetic variants moderate the effects of 
both negative and positive environments on mental health 
and may therefore be important predictors of response to 
psychological treatments. Nevertheless, the identification of 
such variants has so far been limited to preselected candi-
date genes. In this study we extended the differential sus-
ceptibility hypothesis from a candidate gene to a genome-
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enting on emotional problems and the effects of treatment. 
Individuals with a high score responded significantly better 
to individual CBT than group CBT or brief parent-led CBT (re-
mission rates: 70.9, 55.5 and 41.6%, respectively).  Conclu-
sions: Pending successful replication, our results should be 
considered exploratory. Nevertheless, if replicated, they sug-
gest that individuals with the greatest environmental sensi-
tivity may be more likely to develop emotional problems in 
adverse environments but also benefit more from the most 
intensive types of treatment.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Anxiety disorders are among the most prevalent of all 
mental illnesses and some of the earliest to emerge, with 
the vast majority of adult cases beginning in childhood or 
adolescence  [1] . While there is a substantial evidence base 
for the efficacy of psychological treatments for anxiety in 
children, response to treatment varies substantially be-
tween patients  [2] . This means that identifying an effec-
tive treatment can be a long and costly process of trial and 
error that may both delay recovery and have a negative 
effect on long-term outcomes. Genetic predictors of treat-
ment response may allow clinicians to select the most ef-
fective treatment for a given individual at the outset, en-
hancing outcomes and accelerating recovery times  [3] . 
Such predictors could also offer valuable insights into the 
mechanisms underlying response to psychological treat-
ments  [4] .
 The differential susceptibility hypothesis suggests that 
genetic factors moderate the effects of both negative and 
positive environments on mental health – for better and 
for worse  [5] . In line with this hypothesis, individuals 
with 1 or 2 copies of the short allele of the 5-HTTLPR 
have been shown to be at greater risk for mood disorders 
following adversity than individuals homozygous for the 
long allele  [6] . However, these same individuals also ben-
efit more from positive environmental influences such as 
supportive parenting  [7] , positive life events  [8] and so-
cial support  [9] . Importantly, these associations have also 
been shown to extend to moderation of the positive ef-
fects of various interventions including psychosocial 
training on depression  [10] , high-quality foster care on 
disturbances of attachment  [11] and externalizing behav-
iour  [12] , and the efficacy of cognitive behavioural ther-
apy (CBT) in children with anxiety disorders  [13] . In ad-
dition to findings from the 5-HTTLPR, differential sus-
ceptibility has been reported for a small number of further 
markers  [14] , with results from intervention studies 
showing particular promise  [15] . Nevertheless, findings 
have failed to replicate, even in high-quality studies, with 
very similar methodologies  [16, 17] . While the causes of 
non-replication are unclear, one explanation is that envi-
ronmental responsivity is a complex, polygenic trait, 
which is the result of multiple genetic variants of small 
effect rather than a few select candidate genes.
 This suggests that gene-environment interaction 
should move from a candidate gene to genome-wide ap-
proach taking to account the aggregate effects of multiple 
variants  [18] .
 Polygenic scoring allows the effects of multiple vari-
ants to be summarized in a single score. Specifically, al-
leles associated with a trait in a discovery sample at a giv-
en p value threshold are selected in an independent vali-
dation sample, and a score (the sum of these alleles 
weighted by their effect size) is created for each individu-
al  [19] . Using this approach, a recent study reported that 
a polygenic score calculated using the results of a large 
case-control study of major depression moderated the ef-
fects of childhood maltreatment on depression in a fur-
ther sample, with the interaction explaining a further 
0.5% of the variance  [20] . This approach to whole-ge-
nome gene-environment interaction relies on the as-
sumption that genetic variants have a main effect on out-
come. This means that while this method may be suitable 
for detecting variants implicated in diathesis-stress inter-
actions, it may not detect those involved in differential 
susceptibility, which are proposed to have no main effects 
on the phenotype  [5] . One means of targeting these vari-
ants is to explore genetic effects on intra-pair variability 
in outcomes in monozygotic (MZ) twin pairs. As they are 
genetically identical and share the same environment, 
discordance within MZ twin pairs on a measured out-
come is considered to be the result of non-shared envi-
ronmental effects. Genetic variants that increase sensitiv-
ity to the environment should therefore also increase dis-
cordance within MZ twin-pairs, as they render each 
member of the pair more responsive to non-shared envi-
ronmental influences  [21] . While this method has been 
previously used in a genome-wide study of metabolism 
 [22] , it is yet to be applied to analyses of mental health 
outcomes. Moreover, this approach is yet to incorporate 
polygenic scoring to consider of the aggregate effects of 
variants associated with environmental sensitivity. 
 In this study we aimed, for the first time, to test the dif-
ferential susceptibility hypothesis using a genome-wide 
approach. First, we examined associations between ge-
netic variants and intra-pair variability in emotional 
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problems in MZ twins using genome-wide data. Next, in 
order to validate these findings, we calculated a polygen-
ic score of sensitivity to the environment and tested 
whether this score moderated the effects of positive and 
negative parenting on emotional problems in a further 
sample of children. Finally, to test whether these same 
variants moderated response to psychological treatment, 
we tested the polygenic environmental sensitivity score as 
a predictor of treatment response in a sample of children 
and adolescents with anxiety disorders treated with indi-
vidual CBT, group CBT or brief parent-led CBT. 
 In addition to examining the effect of the polygenic 
environmental sensitivity score on overall treatment re-
sponse, we also explored whether the polygenic score pre-
dicted a differential response to the different types of 
treatment received. The effect of environmental sensitiv-
ity on response to psychological treatments with differing 
intensities remains unknown. It has been suggested that 
those with a low sensitivity to the environment may re-
quire a more intensive type of treatment to achieve the 
same results as those who are highly sensitive. In this case, 
individuals with a low sensitivity would respond better to 
individual CBT than brief parent-led CBT. Conversely, it 
has also been argued that individuals with a high sensitiv-
ity to the environment may benefit the most from more 
intensive forms of treatment. In this case individuals with 
a high sensitivity would respond more favourably to in-
dividual CBT compared to lower-intensity treatments 
such as brief parent-led CBT.
 Methods 
 This study utilized 3 samples: a discovery sample, a validation 
sample and a treatment response sample. 
 Discovery and Validation Samples 
 The discovery and validation samples were both drawn from 
the Twins Early Development Study (TEDS). TEDS is an ongoing 
longitudinal study of more than 11,000 twin pairs born in England 
and Wales in 1994, 1995 and 1996, which has been shown to be 
representative of the UK population  [23] . The discovery sample 
included 1,026 MZ twin pairs from TEDS for whom genome-wide 
genotyping data were available, as well as data on emotional prob-
lems at age 12 years. The validation sample included a further 
1,409 unrelated individuals from TEDS (a randomly selected in-
dividual from the remaining dizygotic twins pairs) with available 
data.
 Measures 
 Emotional problems were measured in the discovery and vali-
dation samples at age 12 years using the emotional symptoms sub-
scale of the Strengths and Difficulties Questionnaire  [24] . We cre-
ated a composite score by summing the z scores from child and 
parent reports and dividing by 2. Parenting was assessed at age 12 
years in the validation sample using 2 child report measures: the 
Parental Feelings Questionnaire  [25] and the Parental Strategies 
Questionnaire  [26] . The Parental Feelings Questionnaire includes 
7 statements on the child’s relationship with their parent on a 
3-point scale (very true, quite true or not true). The measure in-
cluded 4 negative items (e.g. ‘I make my parents angry’) and 3 
positive ones (e.g. ‘I feel happy about my relationship with my par-
ents’). Positive items were reversed so that the total score reflected 
parental negativity. The Parental Strategies Questionnaire includ-
ed 4 items in which children were asked to rate on a 3-point scale 
(rarely/never, sometimes or often) what their parent did if they 
misbehaved, including 2 positive (e.g. ‘explain or reason with me’) 
and 2 negative (e.g. ‘they give me a smack’) items. Positive items 
were reversed so that the total score reflected a more negative dis-
cipline strategy. An overall parenting score was created by sum-
ming the standardized scores from both scales. Separate positive 
and negative parenting scores were created by selecting the posi-
tive and negative items from each scale as reported previously in 
the TEDS data  [27] . 
 Genetic Data and Quality Control 
 Both the discovery and validation samples were genotyped as 
part of the larger TEDS sample. Full details of genotyping and 
quality control are provided elsewhere  [28] . In brief, DNA was ex-
tracted from buccal cheek swab samples and genotyped using Af-
fymetrix GeneChip 6.0 single-nucleotide polymorphism (SNP) ge-
notyping arrays. Individuals were removed if they had a low call 
rate or excessive heterozygosity, an atypical population ancestry, 
relatedness or sample duplication or gender mismatches. SNPs 
were excluded if they had a call rate <98%, a minor allele frequen-
cy <1% or a Hardy-Weinberg p value <1 × 10 –20 . Following qual-
ity control, 679,050 SNPs remained for analysis.
 The Treatment Response Sample  
 The treatment response sample was drawn from the Genes for 
Treatment (GxT) study, a multi-site collaboration including 1,519 
individuals which was designed to examine genetic and clinical 
predictors of response to psychological treatments in paediatric 
anxiety disorders. Full details of the sample are available elsewhere 
 [29] . In brief, participants were included if they were aged 5–18 
years (94% were 5–13 years old), met DSM-IV criteria for a pri-
mary diagnosis of an anxiety disorder and provided DNA. Parents 
provided written consent and children gave written or verbal as-
sent. All sites administered the Anxiety Disorders Interview 
Schedule for the DSM-IV, Parent and Child Versions (ADIS-IV-
C/P  [30] ), except for 2 sites where the German equivalent, i.e. the 
Kinder-DIPS, was used  [31] . Participants were assessed before 
and immediately after treatment (post-treatment), with further 
assessments made 3, 6 or 12 months after treatment cessation 
where possible (follow-up). The severity of the primary anxiety 
disorder was measured at each time-point using the Clinician’s 
Severity Rating (CSR) from the structured interview, which as-
signs a score of 0–8 (absent to very severe). A diagnosis was made 
when the child met the diagnostic criteria and received a CSR of 
4 or more. Ten sites (n = 1,396) also assessed comorbid mood 
(major depression or dysthymia) or externalizing disorders (op-
positional defiant disorder, conduct disorder or attention-deficit/
hyperactivity disorder) at baseline using the ADIS-C/P. All assess-
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ments were completed by graduate assistants or clinical staff 
(mainly psychologists) trained in administration of the instru-
ments. Sites have previously reported good inter-rater reliability 
for the diagnostic instruments using these samples  [32–34] . At 8 
sites (n = 1,289), parents also completed the Depression Anxiety 
Stress Scales  [35] , assessing depression, anxiety and stress symp-
toms experienced over the past week. For this study, the 3 sub-
scales were summed to create an overall measure of parental psy-
chopathology.
 Of the 980 participants with available genome-wide genotyping 
data and at least 1 post-baseline assessment, 269 (27.5%) were 
treated with individual CBT, 503 (51.3%) with group-based CBT, 
201 (21.2%) with brief parent-led CBT and 7 (0.7%) with guided 
self-help CBT. In order to limit the heterogeneity of the sample and 
aid the interpretation of treatment-specific effects, individuals 
treated with guided self-help CBT were excluded from the analysis. 
For the remaining 973 participants (54.9% female, mean age 9.8 
years, SD 2.2), primary diagnoses included generalized anxiety dis-
order (n = 362; 37.2%), social anxiety disorder (n = 201; 20.7%), 
specific phobia (n = 106; 10.9%) and separation anxiety disorder 
(n = 223; 22.9%). The remaining participants (n = 81; 8.3%) were 
grouped as ‘other’ anxiety disorders, which included panic disor-
der with and without agoraphobia and agoraphobia without panic 
disorder (n = 26), obsessive-compulsive disorder (n = 34), post-
traumatic stress disorder (n = 13), selective mutism (in patients 
with primary selective mutism, a diagnosis of severe social anxiety 
disorder was also given; the selective mutism was considered by 
the clinician to be primary, the most interfering, n = 2) or anxiety 
disorder not otherwise specified (n = 6). 
 Genetic Data and Quality Control 
 Genotyping and quality control procedures for the GxT study 
are documented elsewhere  [36] . In brief, DNA was extracted from 
buccal swabs and saliva and genotyped on Illumina Human Core 
Exome-12v1.0 microarrays. Individuals with a call rate <99% or 
excessive heterozygosity were removed, as were those with gender 
mismatches or evidence for relatedness or sample duplication. 
SNPs were excluded if they had a call rate <99%, a minor allele fre-
quency <5% or a Hardy-Weinberg p value lower than 1 × 10 –5 . 
Quality-controlled data was imputed to the December 2013 release 
of the 1,000 Genomes Project using IMPUTE2. Only SNPs with an 
information metric >0.8 and a minor allele frequency >1% were 
retained for analysis. 
 Analyses 
 Discovery Sample 
 Discordance in emotional symptom scores was calculated as 
the absolute difference in scores between members of the pair. 
The effects of age, sex and the twin pair’s mean score on emo-
tional symptoms were regressed out to create a residual score, 
which was then included as an outcome variable in a linear re-
gression in PLINK. In order to control for possible effects of pop-
ulation stratification, we included the first 10 principal compo-
nents from previous analyses of the TEDS data  [28] as covariates 
in all analyses. 
 Validation Sample 
 In the validation sample, we aimed to test whether the environ-
mental sensitivity polygenic score moderated the effects of parent-
ing on emotional problems.  Polygenic scores were calculated for 
each individual in the sample using the β and p values from the 
discovery sample. 
 We used increasingly liberal significance thresholds to select 8 
sets of SNPs from the discovery sample that reached p < 0.001, 
0.01, 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5. Prior to inclusion, SNPs were 
pruned for linkage disequilibrium (LD) using p value-informed 
clumping in PLINK employing cut-offs of LD (r 2 = 0.25) and dis-
tance (a 200-kb window). 
 As in the discovery sample, we created a standardized age- and 
sex-regressed residual score of emotional symptoms for individu-
als in the validation sample. We explored the main effects of the 
polygenic environmental sensitivity score and parenting on this 
outcome using linear regressions. Next, we tested whether the 
polygenic score moderated the effects of parenting on emotional 
problems by testing a polygenic score × parenting interaction term 
in these models. The presence of a gene-environment correlation 
(i.e. an effect of the polygenic score on parenting) could poten-
tially bias any polygenic score × parenting interactions. We there-
fore also tested whether our measures of parenting were associated 
with the polygenic score using linear regressions. We included so-
cio-economic status as a covariate, as well as the first 10 principal 
components previously derived from genome-wide analyses of the 
TEDS data  [28] , in order to account for any population stratifica-
tion effects. 
 Treatment Response Sample  
 In the treatment response sample, we aimed to test whether the 
polygenic environmental sensitivity score predicted response to 
psychological treatments. We defined treatment response in the 
GxT sample as the change in severity (CSR score) of the primary 
anxiety diagnosis from baseline to each time point in the study in-
cluding measurements from the post-treatment and 3-, 6- and 
12-month time points. In order to include all of the available out-
come data simultaneously, and provide estimates in the presence 
of missing values, we used a linear mixed model fitted with full 
maximum likelihood. 
 We constructed a model including the fixed effects of baseline 
severity (CSR score of the primary diagnosis at baseline, centred at 
the mean) and the linear and quadratic effects of time to account 
for the curvilinear slope of treatment outcome. To account for cor-
relations between repeated measures from the same subject, all 
models included individuals as a random effect. We also included 
a higher-order random effect of trial to account for between-trial 
differences. As in previous analyses, we covaried for clinical and 
demographic covariates including age, sex, primary diagnosis and 
treatment type by including these as fixed effects. We also includ-
ed the first 10 principal components generated from previous ge-
nome-wide analyses of the GxT data to account for confounding 
caused by population stratification.
 A polygenic environmental sensitivity score was calculated for 
each individual in the GxT sample using the same approach as in 
the validation sample and entered into the above model as a fixed 
effect. First, we tested the effects of the polygenic score on the over-
all treatment response. Next, we tested treatment-specific effects 
by examining the effects of the polygenic score separately in par-
ticipants treated with individual CBT, group CBT or brief parent-
led CBT and by testing for treatment type × polygenic score inter-
actions.
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 Results 
 Discovery Analyses 
 In total, 1,026 MZ twin pairs (56.9% female, mean age 
11.28 years, SD 0.02) with available genome-wide geno-
typing data and data on emotional symptoms were in-
cluded in the discovery analyses. None of the included 
679,050 SNPs reached genome-wide significance; never-
theless, several suggestively significant findings (p < 1 × 
10 –5 ) were identified and are described in  table 1 . 
 Validation Analyses 
 The validation sample included 1,406 unrelated indi-
viduals with available data. The sample was significantly 
younger than the discovery sample (mean age 11.20 years, 
SD 0.70, t = 2.53, p = 0.010) and included significantly 
fewer females (52.1%, χ 2 = 5.33, p = 0.021). However, in-
dividuals did not differ in their mean emotional symp-
toms scores (t = –1.50, p = 0.133). 
 All 679,050 SNPs from the discovery analysis passed 
quality control in the validation sample, and following 
LD-based pruning 155,019 SNPs remained to calculate 
the polygenic environmental sensitivity score. We gener-
ated 8 scores using increasingly liberal significance 
thresholds to select SNPs from the discovery sample (p < 
0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5), which included 
400; 3,161; 13,632; 25,384; 46,752; 66,205; 84,025, and 
100,111 SNPs, respectively.
 Table 2 shows the results of a linear regression explor-
ing the main effects of each polygenic environmental 
sensitivity score and the main effects of parenting on 
emotional problems. The polygenic score was not sig-
nificantly associated with the emotional symptom score, 
and findings were consistent across all significance 
 Table 1.  Associations with intra-pair differences in emotional problems in MZ twins reaching suggestive significance (p < 1 × 10 – 5)
Chromosome SNP ID Position Allele β p value Nearest gene
1 rs12131428 162426451 C 0.3885 2.10 × 10 – 7 UHMK1
22 rs5748871 17603477 A –0.1915 1.63 × 10 – 6 CECR6
19 rs7339483 24462409 G 0.3683 6.20 × 10 – 6 ZNF254
5 rs3864261 72358254 A 0.2662 7.33 × 10 – 6 FCHO2
8 rs10875469 142333425 T –0.2144 9.29 × 10 – 6 GPR20
5 rs1392412 72362289 G 0.2631 9.41 × 10 – 6 FCHO2
 Table 2.  Validation analyses: linear regression examining the main effects of polygenic environmental sensitivity score and parenting 
and their interaction on emotional problems
p value 
threshold
Main effects of polygenic environ-
mental sensitivity scorea
Main effects of parentinga Polygenic environmental sensitivity
 score × parenting interactionb
β 95% CI p β 95% CI p  β 95% CI p R2, %
0.001 –0.01 –0.04 to 0.05 0.869 0.21 0.17 to 0.25 4. 43 × 10 – 22 –0.04 –0.08 to 0.01 0.107 0.05
0.01 –0.01 –0.05 to 0.03 0.718 0.21 0.17 to 0.25 4.65 × 10 – 22 0.01 –0.05 to 0.04 0.848 0.01
0.05 0.01 –0.03 to 0.05 0.615 0.21 0.17 to 0.25 4.54 × 10 – 22 0.04 –0.01 to 0.08 0.085 0.22
0.1 0.02 –0.03 to 0.06 0.470 0.21 0.17 to 0.25 4.38 × 10 – 22 0.05 0.00 to 0.09 0.035 0.33
0.2 0.01 –0.03 to 0.05 0.727 0.21 0.17 to 0.25 4.58 × 10 – 22 0.06 0.01 to 0.10 0.011 0.47
0.3 –0.01 –0.05 to 0.04 0.787 0.21 0.17 to 0.25 4.60 × 10 – 22 0.06 0.01 to 0.10 0.012 0.46
0.4 –0.01 –0.05 to 0.03 0.636 0.21 0.17 to 0.25 4.52 × 10 – 22 0.06 0.02 to 0.10 0.008 0.49
0.5 –0.01 –0.05 to 0.03 0.640 0.21 0.17 to 0.25 4.49 × 10 – 22 0.06 0.02 to 0.10 0.005 0.53
 a Models included the main effects of polygenic environmental sensitivity score and child-reported parenting on age- and sex-re-
gressed combined child-/adult-rated emotional symptom scores. b Models included the main effects of polygenic environmental sensi-
tivity score and child-reported parenting and their interaction on age- and sex-regressed combined child-/adult-rated emotional symp-
tom scores. To account for possible effects of population stratification, all models also included the first 10 principal components previ-
ously derived from genome-wide analyses of the TEDS data.
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thresholds. There was a significant main effect of parent-
ing on emotional problems in the expected direction, 
with more negative parenting associated with increased 
emotional symptom scores. In order to investigate 
whether the polygenic environmental sensitivity score 
moderated the effects of parenting on emotional prob-
lems, we added an interaction term to the above models. 
Significant interactions were identified for polygenic 
scores calculated using 5 of the 8 p value thresholds. In-
teraction effects began to emerge when a threshold of
p < 0.1 was used in the discovery sample where they ex-
plained an additional 0.33% of the variance. The addition 
of further SNPs strengthened these effects, which were 
greatest for the polygenic scores based on a threshold of 
p < 0.5 where the interaction term explained an addi-
tional 0.53% of the variance. The interaction from this 
model is illustrated in  figure 1 , in which the polygenic 
score (based on a threshold of p < 0.5) is divided into 
equal tertiles to represent low, moderate and high scores 
and the parenting score is separated into equal tertiles to 
represent negative, moderate and positive parenting. 
Findings were in the expected direction. Specifically, for 
individuals with a low polygenic environmental sensitiv-
ity score, parenting had little effect on emotional prob-
lems. However, for those with a higher polygenic score, 
negative parenting was associated with an increased 
emotional symptom score, while positive parenting was 
associated with decreased scores.
 To explore these interaction effects further, we re-an-
alysed the data considering the effects of positive and neg-
ative aspects of parenting separately (see online suppl. 
tables S1, S2; for all online supplement material, see www.
karger.com/doi/10.1159/000444023). Findings were con-
sistent with those from the above analyses. Specifically, in 
individuals with a high polygenic score, negative parent-
ing was associated with increased emotional problems, 
while positive parenting was associated with decreased 
emotional symptom scores. Conversely, in those with a 
low polygenic score, neither positive nor negative parent-
ing had an effect on emotional problems. There was no 
evidence for a gene-environment correlation. That is, 
there was no significant association between the polygen-
ic environmental sensitivity score at any of the measured 
thresholds and any of our measures of parenting (online 
suppl. table S3). Finally, to test whether the same interac-
tion effects were observed across raters, we re-analysed 
the data using child-reported emotional problems and 
parent-reported parenting. The findings were similar to 
those from our initial analysis, showing significant inter-
action effects which emerged when using a threshold of
p < 0.2 (online suppl. table S4).
 Treatment Response Analyses 
 We used a linear mixed model to identify predictors of 
response (change in the severity of the primary diagno-
sis). Initially we explored the effects of clinical and demo-
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 Fig. 1. Effects of the polygenic environ-
mental sensitivity score, parenting and 
their interaction on emotional problems. 
Mean standardized emotional symptom 
score by tertiles of parenting (representing 
negative, moderate and positive parenting) 
and tertiles of the polygenic environmental 
sensitivity score (low, moderate and high, 
threshold: p < 0.5). Error bars represent 1 
standard error. 
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graphic factors and the findings were similar to those re-
ported for the full sample  [29] . Specifically, individuals 
with social anxiety disorder or a specific phobia showed 
a significantly poorer response to treatment than those 
with generalized anxiety disorder (β = 0.43, p < 0.001, and 
β = 0.19, p = 0.013, respectively). However, treatment re-
sponse did not differ according to any other factors in-
cluding sex, age or treatment type (all p > 0.05). 
 In total, 277,893 SNPs from the discovery analysis 
were available in the treatment response sample, and fol-
lowing LD-based pruning 72,375 remained for calcula-
tion of the polygenic environmental sensitivity score. We 
generated 8 scores using increasingly liberal significance 
thresholds to select SNPs from the discovery sample (p < 
0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5), which included 
159; 1,295; 5,905; 10,988; 20,423; 29,461; 37,668, and 
45,371 SNPs, respectively. 
 The polygenic score did not significantly predict over-
all response to treatment, and results were consistent 
across the different thresholds used to calculate the score 
( table  3 ). However, the polygenic score did have treat-
ment-specific effects. Specifically, while the score was 
positively associated with response to individual CBT it 
was negatively associated with response to brief parent-
led CBT. These effects only emerged when the polygenic 
score included SNPs reaching p < 0.05 in the discovery 
sample. At this threshold, it explained 1.55% of the vari-
ance of response to individual CBT and 4.80% of the var-
iance of response to brief parent-led CBT. While the ad-
dition of further SNPs improved the p value of these as-
sociations for brief parent-led CBT, they did not 
substantially improve the variance explained. 
 We further explored the treatment-specific effects of 
the polygenic score on outcome by testing for treatment 
type × polygenic score interactions. These analyses 
showed that the polygenic score (based on SNPs reaching 
p < 0.05 in the discovery sample) significantly moderated 
the effect of each treatment type on outcome (individual 
vs. group CBT × polygenic score interaction: β = –0.13, 
95% CI –0.24 to 0.02, p = 0.02; individual vs. brief parent-
led CBT × polygenic score interaction: β = –0.30, 95%
CI = –0.42 to 0.17, p = 3.1 × 10 –6 , and group CBT vs. brief 
parent-led CBT × polygenic score interaction: β = –0.15, 
95% CI –0.26 to 0.04, p = 0.007). 
 For those with a low polygenic environmental sensi-
tivity score, treatment type had little effect on outcome. 
However, those with a high polygenic score responded 
well to individual CBT, moderately to group CBT and 
poorly to brief parent-led CBT. These effects are illus-
trated in  figure 2 , which shows the mean change in anx- Ta
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iety severity scores between baseline and the post-treat-
ment time point by tertiles of low, moderate and high 
polygenic scores (using the threshold of p < 0.05). Figure 
3 shows the percentage of individuals in remission at the 
post-treatment time point by tertiles of low, moderate 
and high polygenic scores. For those in the lower tertile, 
rates of remission were similar across treatment types. 
However, remission rates differed markedly in those 
with a high polygenic environmental sensitivity score 
(70.9%, 55.5% and 41.6%, for individual, group and brief 
parent-led CBT, respectively).
 As all analyses included baseline anxiety severity, di-
agnosis, age and gender as covariates, these factors are 
unlikely to confound the relationship between the poly-
genic score and treatment response. However, we previ-
ously showed that comorbid externalizing and internal-
izing disorders [measured in a subset of the sample (n = 
935)], as well as parental psychopathology, [measured in 
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 Fig. 2. Effects of the polygenic environ-
mental sensitivity score on the change in 
clinical severity rating score from baseline 
to the post-treatment time point. Mean 
change in clinical severity rating from base-
line to post-treatment for individuals treat-
ed with individual CBT, group CBT and 
brief parent-led CBT by tertiles of the poly-
genic environmental sensitivity score (low, 
moderate and high). Error bars represent 1 
standard error. 
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 Fig. 3. Effects of the polygenic environ-
mental sensitivity score on the percentage 
of individuals in remission at the post-
treatment time point. Percentage of indi-
viduals in remission at the post-treatment 
time point for individuals treated with in-
dividual CBT, group CBT and brief parent-
led CBT by tertiles of the polygenic envi-
ronmental sensitivity score (low, moderate 
and high). Error bars represent 1 standard 
error. 
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a smaller subset (n = 816)] were associated with treatment 
response. Linear and logistic regressions showed that the 
polygenic score was not significantly related to parental 
psychopathology or the presence of comorbid external-
izing disorders but was significantly associated with a 
lower likelihood of comorbid internalizing disorders at 
the majority of the polygenic score thresholds tested (see 
online suppl. table S5).
 In order to exclude the possibility that the presence of 
comorbid internalizing disorders confounded the rela-
tionship between the polygenic scores and treatment re-
sponse, we re-ran analyses controlling for this variable on 
the subsample in which they were available. The findings 
were similar to those from the main analysis (see online 
suppl. table S6). 
 Finally, the non-random allocation of treatments 
meant that individuals in each treatment group differed 
on several clinical and demographic factors including 
baseline severity, diagnosis, age, parental psychopathol-
ogy and comorbid externalizing and internalizing disor-
ders (see online suppl. table S7). To ensure that interac-
tions between polygenic score and treatment type on out-
come were not biased by these differences, we used 
propensity score matching to restrict analyses to individ-
uals across treatment types who were matched for base-
line severity, age, diagnosis, comorbid externalizing and 
internalizing disorders and parental psychopathology 
[see online suppl. material (Methods)]. Using this re-
duced sample, interaction effects were of a similar mag-
nitude to those reported for the main analyses (individu-
al vs. brief parent-led CBT × polygenic score interaction: 
β = –0.28, 95% CI –0.46 to 0.09, p = 0.003, and group CBT 
vs. brief parent-led CBT × polygenic score interaction:
β = –0.15, 95% CI = –0.29 to 0.01, p = 0.041), suggesting 
that they were not the result of measured differences be-
tween treatment types at baseline. 
 Discussion 
 The differential susceptibility hypothesis suggests that 
the same genetic variants moderate the effects of both 
positive and negative environments on mental health. 
While several candidate gene studies support this hy-
pothesis, this study is the first to find evidence for differ-
ential susceptibility using a genome-wide approach. We 
used an MZ differences design to detect variants that in-
crease the effects of the environment on the development 
of emotional problems. Consistent with the differential 
susceptibility hypothesis, we found that a polygenic envi-
ronmental sensitivity score based on these findings mod-
erated the effects of both positive and negative parenting 
on emotional problems in a further sample of children. 
The same polygenic score also moderated response to dif-
ferent psychological treatments in children with anxiety 
disorders.
 Main Findings 
 We examined within-pair variability in emotional 
symptoms in MZ twins to detect genetic variants associ-
ated with increased sensitivity to the environment. None 
of our findings reached genome-wide significance. Nev-
ertheless, suggestively significant associations were iden-
tified in a region containing  UHMK1,  a gene that encodes 
the brain-enriched protein kinase KIS. Animal models 
suggest that  UHMK1 is highly expressed in the brain, and 
knockdown of this gene effects the development of corti-
cal neurons in culture  [37] . In line with our findings, 
 UHMK1 knockout mice display a distinct deficit in fear 
conditioning, which is accompanied by downregulation 
of genes implicated in the aetiology of anxiety and fear, 
including multiple components of GABA A receptors 
 [38] . 
 Consistent with our hypothesis, a polygenic environ-
mental sensitivity score based on the whole-genome re-
sults significantly moderated the effects of parenting on 
emotional problems in an unrelated sample. In line with 
the differential susceptibility hypothesis, this interaction 
applied to both positive and negative aspects of parenting. 
In individuals with a low environmental sensitivity, par-
enting had little effect on emotional problems. However, 
in those with a high environmental sensitivity, negative 
parenting was associated with increased emotional prob-
lems, while positive parenting was associated with de-
creased emotional symptom scores. Although statistically 
significant, the effects of the environmental sensitivity × 
environment interactions were very small, explaining at 
most an additional 0.53% of the variance in outcome. 
Nevertheless, these findings are comparable to those re-
ported for the main effects of polygenic scores and poly-
genic score × environment interactions in a previous 
study of major depression  [20] . The variance explained 
was also larger than that reported for the main effects of 
polygenic scores on depression symptoms in a population 
sample  [39] .
 While the polygenic environmental sensitivity score 
did not predict overall response to treatment, it did sig-
nificantly predict differential response to individual CBT, 
group CBT and brief parent-led CBT. Importantly, these 
findings were not confounded by measured baseline clin-
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ical or demographic characteristics or biased by mea-
sured differences between treatment groups. The effects 
of environmental sensitivity appeared to increase linearly 
with the intensity of the treatment delivered, such that 
those with the highest environmental sensitivity respond-
ed best to individual CBT, moderately to group CBT and 
poorly to brief parent-led CBT. In contrast, those with a 
low environmental sensitivity responded equally well to 
each treatment type. The variance explained by the poly-
genic score was modest (1.62% in those treated with indi-
vidual CBT and 5.77% in those treated with parent-led 
guided self-help) but nevertheless comparable to those in 
previous studies of treatment response using a polygenic 
approach  [40] . 
 Previous studies have created cumulative scores of en-
vironmental sensitivity based on small sets of hypothe-
sized differential susceptibility alleles and tested them as 
moderators of the environment  [41] and predictors of the 
treatment response  [3] . However, this study was the first 
to use an MZ difference or genome-wide approach to de-
tect and weight alleles according to their effect on envi-
ronmental sensitivity. Nevertheless, our findings are con-
sistent with those of candidate gene studies in which spe-
cific variants have been shown to enhance the effects of 
both negative and positive parenting on internalizing and 
externalizing phenotypes  [14] , response to CBT  [13] and 
a range of interventions for internalizing and externaliz-
ing behaviour  [15] . 
 To our knowledge this is the first study examining the 
effects of sensitivity to the environment on response to 
CBT of varying intensity. It has been argued that indi-
viduals with a low sensitivity to the environment may re-
quire a more intensive type of treatment to achieve the 
same results as those who are highly sensitive. Our find-
ings do not support this hypothesis. Outcomes for those 
with a low sensitivity to the environment were the same, 
regardless of the intensity of the treatment provided. In 
those with a high environmental sensitivity, the intensity 
of treatment was positively correlated with outcome such 
that they derived the most benefit from the most intensive 
forms of treatment. This finding is in line with the differ-
ential susceptibility hypothesis, which suggests that in-
creasing exposure to an environment (positive or nega-
tive) has a greater effect on environmentally sensitive per-
sons compared to environmentally insensitive individuals. 
 A more complete explanation may be that individuals 
with increased genetic sensitivity to the environment de-
velop more of the cognitive biases underlying anxiety dis-
orders (such as a bias towards threat)  [42] and therefore 
require more intensive treatments to overcome these ab-
errant cognitions. A prospective longitudinal study with 
data both at the onset of illness and throughout treatment 
would be necessary to directly test this hypothesis. Such 
a design would allow for the investigation of aetiological 
factors  [43] , as well as the effects of the course of illness 
and disease progression  [44] . 
 Implications 
 If replicated, our findings may have several important 
implications for understanding the aetiology of emotion-
al problems and treatment response. 
 We found that our polygenic environmental sensitiv-
ity score was only a significant moderator of parenting or 
treatment response when it included variants reaching 
thresholds of p < 0.1 and p < 0.05, respectively, in the dis-
covery dataset. This suggests that sensitivity to the envi-
ronment, rather than being the result of the effects of a 
handful of candidate genes, is a polygenic trait, which is 
due to the aggregate effects of tens of thousands of vari-
ants of small effect. These polygenic effects may explain 
why previous studies of gene-environment interactions, 
which focus on a single candidate gene, often fail to rep-
licate. 
 A previous polygenic score study, which assumed a di-
athesis stress model, suggested that around 0.5% of the 
variance in liability to major depression is accounted for 
by gene-environment interaction  [20] . We report that a 
similar amount of variance in the aetiology of emotional 
problems is accounted for by variants operating in a man-
ner consistent with differential susceptibility. A signifi-
cant role of such variants may explain why, despite mod-
erate estimates of heritability, attempts to identity the ge-
netic variants responsible for child anxiety and depression 
have so far been unsuccessful  [28] . They may also explain 
why SNP level heritability estimates are also considerably 
lower than those predicted from twins, even within the 
same samples  [45] . 
 Polygenic predictors of environmental sensitivity may 
allow a more accurate identification of those who are at 
risk of developing disorders in the face of adversity but 
also those who are most likely to benefit from intensive 
treatments. Previous findings from the current sample 
suggested that treatment type had little overall effect on 
outcome  [29] . Indeed, a recent meta-analysis reported 
that individual CBT or group CBT was as effective as low-
er-intensity self-help approaches  [2] . However, our re-
sults suggest that the efficacy of different treatment types 
differs markedly according to environmental sensitivity. 
These effects are potentially clinically meaningful, with 
remission rates in the upper tertile of the polygenic score 
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of 70.9, 55.1 and 40.6% for individual CBT, group CBT 
and brief parent-led CBT, respectively. If replicated, our 
findings suggest that for those with a relatively low ge-
netic sensitivity to the environment, more cost-effective, 
lower-intensity approaches are equally as effective as 
face-to-face treatment. More importantly, they also sug-
gest that response rates may be substantially improved by 
targeting those with an increased genetic sensitivity to the 
environment with the most intensive psychological ther-
apies. 
 Strengths and Limitations 
 It has been noted that there are two principal chal-
lenges facing gene-environment interaction research: the 
necessity to develop methods which include the whole 
genome and the need to develop those which include and 
reliably measure the whole ‘environome’ of relevant en-
vironments  [18] . By assessing the aggregate effects of ge-
netic variants from across the genome on unmeasured 
non-shared environmental effects, the current study si-
multaneously addresses both of these challenges. Never-
theless, our findings should be interpreted in the light of 
several important limitations.
 First, while our discovery analyses used a large, well-
characterized sample of MZ twins, it was only adequately 
powered (80%) to detect individual variants with moder-
ate effects on environmental sensitivity at genome-wide 
significance (explaining more than 1% of the variance of 
the variance)  [21] . Although our polygenic approach did 
not rely solely on genome-wide significant findings, the 
discovery, validation and treatment samples were smaller 
than recommended for polygenic score analyses, particu-
larly when testing treatment-specific effects  [19] . Our 
findings should therefore be considered exploratory, 
pending replication in further, larger samples. 
 Second, we aimed to identify genetic variants that 
moderated the effects of the non-shared environment on 
emotional problems. We chose to validate these findings 
by exploring the interaction between our polygenic envi-
ronmental sensitivity score and child-reported parenting 
as this is one of the most robust environmental predictors 
of child anxiety  [46] and it has been shown to be moder-
ated by genetic factors in a manner consistent with dif-
ferential susceptibility  [7] . We identified similar interac-
tions in cross-rater analyses (using parent-rated parent-
ing and child-rated emotional problems), and the same 
variants also moderated response to psychological treat-
ment. However, it remains unknown whether these find-
ings extend to more objectively measured environments 
such as observed parenting. 
 Finally, our treatment response sample included chil-
dren with anxiety disorders receiving psychological treat-
ment as part of a trial or treatment as usual in one of mul-
tiple studies  [29] . The subsequent non-random alloca-
tions of treatments meant that treatment type was 
associated with several clinical and demographic charac-
teristics at baseline. While additional analyses using pro-
pensity score matching allowed us to conclude that our 
findings were not biased by measured differences be-
tween treatment groups, we cannot exclude the possibil-
ity that individuals differed by unmeasured factors. Rep-
lication of our findings in a randomized trial comparing 
low- and high-intensity CBT is therefore necessary to ful-
ly exclude the effects of confounding by indication. 
 Conclusion 
 The limited power provided by the cohorts used in 
each stage of our study means that our results should be 
considered exploratory until successfully replicated in 
larger samples. Nevertheless, if replicated, our findings 
suggest that responsivity to the environment is the result 
of multiple genetic variants of small effect rather than a 
few select candidate genes. We showed that these variants 
moderated the effects of parenting on the development of 
emotional problems in children. The same variants also 
predicted a differential response to psychological treat-
ments, such that those with the greatest sensitivity to the 
environment appeared to benefit the most from more in-
tensive types of treatment. In line with previous polygen-
ic score studies, the gene × environment effects we identi-
fied explained a very small proportion of the variance 
(0.53%). However, the variance explained by gene × treat-
ment effects was larger (1–5%). The potential clinical util-
ity of these findings warrants further investigation of 
these effects in patients receiving low- and high-intensity 
CBT.
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